Bone markers as screening strategy for patient adherence to osteoporosis medications

This IOF and ECTS Working Group position paper proposes measuring specific bone turnover markers (BTMs) in patients who have initiated use of oral bisphosphonates for postmenopausal osteoporosis as a practical way to identify low adherence. BTMs can reflect the early effect of the drug on bone tissue. If low response is detected shortly after treatment begins, this may indicate low adherence or point to underlying causes of impaired response to medication.

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

BTMs [+]   

More #news: